These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27846973)

  • 1. Reply to: "Re: Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study".
    Hamzavi IH; Zarbo A; Lim HW
    J Am Acad Dermatol; 2016 Dec; 75(6):e233. PubMed ID: 27846973
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study".
    Amerson EH; Murphy E
    J Am Acad Dermatol; 2016 Dec; 75(6):e231. PubMed ID: 27846972
    [No Abstract]   [Full Text] [Related]  

  • 3. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
    Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases.
    van Geel N; Speeckaert M; Brochez L; Lambert J; Speeckaert R
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):741-6. PubMed ID: 23590677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo: Pathogenesis, clinical variants and treatment approaches.
    Iannella G; Greco A; Didona D; Didona B; Granata G; Manno A; Pasquariello B; Magliulo G
    Autoimmun Rev; 2016 Apr; 15(4):335-43. PubMed ID: 26724277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of IL-17 in vitiligo: A review.
    Singh RK; Lee KM; Vujkovic-Cvijin I; Ucmak D; Farahnik B; Abrouk M; Nakamura M; Zhu TH; Bhutani T; Wei M; Liao W
    Autoimmun Rev; 2016 Apr; 15(4):397-404. PubMed ID: 26804758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aetiology of vitiligo.
    Lancet; 1971 Dec; 2(7737):1298-9. PubMed ID: 4143544
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vitiligo: nothing new?].
    Naeyaert JM; Ongenae K; Van Geel N
    Ann Dermatol Venereol; 2003 Mar; 130(3):309-11. PubMed ID: 12746664
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of interleukin-17 in the pathogenesis of vitiligo.
    Bassiouny DA; Shaker O
    Clin Exp Dermatol; 2011 Apr; 36(3):292-7. PubMed ID: 21198791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitiligo and other endocrine complications with an autoimmune basis].
    Herrera Pombo JL; Rodríguez ME; Rovira A; Martínez J; Salvador ML; Pérez Naranjo JM; de Castro A; Orbaneja JG
    Rev Clin Esp; 1982 Dec; 167(5):321-5. PubMed ID: 6897748
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting iHSP 70 in vitiligo: a critical step for cure?
    Taïeb A; Seneschal J
    Exp Dermatol; 2013 Sep; 22(9):570-1. PubMed ID: 23947669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity and vitiligo.
    Harsoulis P; Kanakouki-Tsakalidis F; Vyzantiadis A; Minas A; Cassimos C
    Arch Dermatol; 1978 Oct; 114(10):1554. PubMed ID: 718207
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo: auto-immunity and immune responses.
    Sehgal VN; Srivastava G
    Int J Dermatol; 2006 May; 45(5):583-90. PubMed ID: 16700798
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study.
    Ingordo V; Cazzaniga S; Raone B; Digiuseppe MD; Musumeci ML; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Battarra VC; Sirna R; Patrizi A; Naldi L
    Dermatology; 2014; 228(3):240-9. PubMed ID: 24603479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of experimental autoimmune vitiligo by oral administration of mushroom tyrosinase.
    Zehtab T; Yazdanparast R; Rafieii S
    Cytobios; 2001; 105(408):27-34. PubMed ID: 11368265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo associated with regional enteritis.
    Monroe EW
    Arch Dermatol; 1976 Jun; 112(6):833-4. PubMed ID: 942216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome?
    Peserico A; Rigon F; Semenzato G; Caretto A; Pasini CV; Betterle C
    Arch Dermatol; 1981 Nov; 117(11):751-2. PubMed ID: 7316541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.